Givaudan stock holds below consensus as half-year earnings normalize

Givaudan SA (ISIN CH0010645932) stock is quoted at CHF 3,211.00 per share as of August 17, 2026, leaving the Swiss fragrance and flavors group below a CHF 3,501.33 consensus target compiled on the same date and underscoring a measured valuation gap between market pricing and analysts' expectations. Per recent half-year reporting for 2026, the company generated revenue of CHF 3.86 billion while net income rose to CHF 592.00 million, offering investors a picture of resilient profitability despite slightly softer top-line momentum relative to forecasts. For equity holders, the combination of a modest discount to consensus and solid earnings growth sets the stage for a nuanced debate on upside versus execution risk.

Half-year 2026 earnings show profit growth

According to a recent earnings overview covering the latest half-year period in 2026, Givaudan reported revenue of CHF 3.86 billion, which came in below the CHF 3.93 billion that had been estimated beforehand and highlighted a shortfall of CHF 0.07 billion versus expectations. In the same half-year, earnings reached CHF 63.85 per share compared with an estimated CHF 66.04 per share, resulting in an earnings surprise of minus 3.32 percent and signaling that profit delivery was modestly weaker than the consensus projection. Despite this miss against forecasts, net income for the half-year climbed from CHF 502.00 million in the prior comparable half-year to CHF 592.00 million, marking a 17.93 percent increase and illustrating that the underlying profit trend remains positive even as reported earnings per share eased against analysts' models. The company also reported EBITDA of CHF 1.80 billion for the period, corresponding to an EBITDA margin of 23.87 percent, which underscores the strong profitability levels that continue to characterize the fragrance and flavors franchise.

The same earnings compilation points to a sector backdrop where beauty-related divisions have been able to sustain growth. Data on fragrance houses shows that the beauty divisions of several peers delivered a weighted average organic growth of 5.2 percent in the first half of 2026 and accelerated in the second quarter to 6.7 percent, with fine fragrance remaining an important growth engine overall. Within this context, Givaudan's Fragrance & Beauty segment generated sales of EUR 2,140 million in the first half, up 6.5 percent at constant rates, while growth in the second quarter reached 7.1 percent driven by consumer products demand. This segment performance aligns with the broader sector pattern of accelerating organic growth in the second quarter and adds nuance to the headline figures from the consolidated half-year report.

Consensus expectations point to normalization

The latest consensus projections for the next half-year period suggest that analysts expect a degree of normalization after the strong profit expansion recorded in the last half-year. The compiled estimates call for earnings of CHF 59.61 per share in the upcoming half-year, compared with CHF 63.85 per share just delivered, indicating a projected decline of CHF 4.24 per share that would trim reported earnings relative to the recent peak. On the revenue line, consensus points to CHF 3.67 billion for the next half-year, which stands below the CHF 3.86 billion reported for the latest period and implies a reduction of CHF 0.19 billion as models adjust for a more moderate growth environment. Taken together, these expectations frame a scenario in which Givaudan maintains robust profitability but sees a modest cooling in both revenue and earnings metrics compared with the strong first half of 2026.

This earnings outlook sits against a valuation picture in which Givaudan stock continues to trade modestly below the prevailing target price. The shares are currently quoted at CHF 3,211.00 as of August 17, 2026, while the consensus target of CHF 3,501.33 on the same date implies potential upside of CHF 290.33 per share if the stock were to converge toward the analysts' central valuation. Market data from the same session indicates that the last official closing price stood at CHF 3,225.00, providing a clear short-term reference point for the trading range around the consensus benchmark and suggesting that the stock is oscillating in a band slightly under the modeled fair value. In parallel, the company commands a market capitalization of CHF 32.03 billion on this price basis, placing Givaudan among Europe's larger specialty chemicals and ingredients names and reinforcing the notion that investor discussions now center more on the sustainability of margins and growth than on the company's basic scale.

Fragrance & Beauty segment underpins growth

Beyond the consolidated figures, Givaudan's business mix sheds further light on how growth is being generated. In the Fragrance & Beauty division, first-half 2026 sales of EUR 2,140 million, up 6.5 percent at constant rates, demonstrate that demand for fine fragrance, personal care, and related applications remains solid. The acceleration to 7.1 percent growth in the second quarter, driven by consumer products, highlights a dynamic in which volume and mix improvements across everyday beauty categories complement more premium fragrance offerings. This pattern matters for equity investors because it suggests that the company is not solely dependent on cyclical luxury demand; instead, it draws on a diversified base of end markets that can help cushion volatility in any single segment.

Sector data showing a weighted average organic growth of 5.2 percent in the first half among major fragrance houses, and a rise to 6.7 percent in the second quarter, situates Givaudan within a group of peers that have collectively accelerated their beauty-related businesses. In this landscape, Givaudan's 6.5 percent first-half growth and 7.1 percent second-quarter growth in Fragrance & Beauty place it slightly ahead of the peer average, hinting that its portfolio and innovation pipeline may be contributing to a modest outperformance in organic expansion. For shareholders, such relative positioning can be an important factor when assessing whether a premium valuation is justified and whether the current discount to the consensus target offers a meaningful entry point in light of competitive dynamics.

Representative product: fine fragrance creations

A representative example of how Givaudan translates its capabilities into commercial offerings is the company's work in fine fragrance creations for global brands. In this area, Givaudan collaborates closely with perfumers and consumer goods companies to design signature scents that align with brand identity, target demographics, and regional preferences, often using proprietary molecules and formulation technologies to achieve distinctive olfactory profiles. These fine fragrance products feed into premium segments of the beauty and personal care market, where margins tend to be higher and brand loyalty deeper, thereby supporting the company’s overall profitability metrics. At the same time, the know-how developed in fine fragrance often cascades into mass-market and functional fragrance applications, reinforcing the breadth of Givaudan's portfolio and contributing indirectly to the steady organic growth observed in its Fragrance & Beauty division.

Givaudan stock valuation and latest price context

From a stock-market perspective, Givaudan shares are currently trading on the Swiss market, with the latest quoted level of CHF 3,211.00 as of August 17, 2026, serving as the operative reference point for investors. On this basis, the company’s market capitalization of CHF 32.03 billion reflects a substantial valuation that is nevertheless below the aggregate target price indicated by consensus, reinforcing the theme of a moderate gap between modeled fair value and actual trading levels. For retail investors and institutional holders alike, the interplay between durable margins, a forecast normalization in earnings, and a share price that sits under the consensus target will likely remain central to how Givaudan stock is assessed in the coming months.

Go deeper

Investors looking for a fuller picture of Givaudan stock can consult recent market data and earnings summaries that detail the half-year 2026 performance, including revenue, earnings per share, net income, and segment growth metrics. These resources help contextualize the current trading level relative to consensus expectations and the company’s historical profit trajectory.

Investor Relations

More on Givaudan stock

Fact box

Company: Givaudan SA

ISIN: CH0010645932

Ticker: GIVN

Exchange: SIX Swiss Exchange

Price (as of August 17, 2026): CHF 3,211.00

Market cap: CHF 32.03 billion (as of August 17, 2026)

Sector / Industry: Specialty chemicals - fragrances and flavors

Index membership: SMI